Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
JP3463000004
Thu, 09.05.2024
Takeda Pharmaceutical Company Limited
OSAKA, Japan, May 9, 2024 – Takeda (TSE:4502/NYSE:TAK) announced that its Board of Directors today approved a significant multi-year program focused on organizational agility, spending efficiencies and leveraging the company’s capabilities in data, digital and technology (DD&T). The program aims to improve growth through continued advancement o [ … ]
Thu, 26.10.2023
Takeda Pharmaceutical Company Limited
Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)
OSAKA, Japan, October 26, 2023 - Takeda (TSE:4502/NYSE:TAK) today announced the revised forecast of the full year consolidated financials for the fiscal year ending March 31, 2024, as below.
Revised Forecast for Full Year Consolidated Financials for the [ … ]
Thu, 03.02.2022
Takeda Pharmaceutical Company Limited
Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
Osaka, Japan, February 3, 2022 - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced the revised forecast of the full year consolidated financials for the fiscal year ending March 31, 2022, as below.
1. Revised Forecast for Full Year Conso [ … ]
Thu, 29.10.2020
Takeda Pharmaceutical Company Limited
Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
Osaka, Japan, October 29, 2020 - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") announced today, the revised forecast of the full year consolidated financials for the fiscal year ending March 31, 2021, as below.
1. Revised Forecast for Full Year Cons [ … ]
Mon, 24.08.2020
Takeda Pharmaceutical Company Limited
Takeda to Divest its Japan Consumer Health Care Business Unit
to Blackstone for JPY 242.0 Billion
Transaction further sharpens Takeda's focus on five key business areas
Consumer Health Care Business to continue serving consumers in Japan and Asia under new owner
Osaka, Japan, August 24, 2020 - Takeda Pharmaceutical Company Limited (TSE:4502/NYS [ … ]
Fri, 31.07.2020
Takeda Pharmaceutical Company Limited
Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
Osaka, Japan, July 31, 2020 - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") announced today, the revised forecast of the full year consolidated financials for the fiscal year ending March 31, 2021, as below.
1. Revised Forecast for Full Year Consoli [ … ]